Table 1 Basic information of included studies
Study ID | First author | Year of publication | Study design | Sample size(n) | Follow-up period | Outcomes | |
|---|---|---|---|---|---|---|---|
LD-IVIg | HD-IVIg | ||||||
1 | Bao H [26] | 2017 | RCT | 44 | 44 | 3 months | ER; DR; AR |
2 | He WD [27] | 2017 | RCT | 48 | 48 | 3 months | ER DR; AR Time of PC starting to rise; Time of PC rising to normal; Time of achieving hemostasis |
3 | Hou ZH [35] | 2021 | RCT | 58 | 58 | Not reported | ER |
4 | Ji LJ [29] | 2022 | RCT | 46 | 46 | Not reported | ER; AR Time of PC rising to normal Time of achieving hemostasis |
5 | Luo F [42] | 2017 | RCT | 45 | 45 | Not reported | ER Time of PC starting to rise; Time of achieving hemostasis |
6 | Su BX [44] | 2016 | RCT | 38 | 40 | 3 months | ER; DR; AR Time of PC starting to rise; Time of PC rising to normal; Time of achieving hemostasis |
7 | Qin HZ [38] | 2015 | RCT | 40 | 40 | 3 months | ER; DR; AR Time of PC starting to rise; Time of PC rising to normal; Time of achieving hemostasis |
8 | Yang YX [47] | 2019 | RCT | 34 | 33 | 3 months | ER; DR; AR Time of achieving hemostasis |
9 | Yu ZJ [48] | 2018 | RCT | 60 | 60 | 3 months | ER; DR Time of PC starting to rise; Time of PC rising to normal; Time of achieving hemostasis |
10 | Zhu W [50] | 2014 | RCT | 65 | 65 | Not reported | ER; AR |
11 | Zhao SL [49] | 2018 | RCT | 17 | 17 | 6 months | ER; DR; AR Time of PC starting to rise; Time of PC rising to normal Time of achieving hemostasis |
12 | Feng L [30] | 2019 | RCT | 34 | 34 | 3 months | ER; DR; AR Time of PC starting to rise; Time of PC rising to normal |
13 | He WH [34] | 2019 | RCT | 31 | 31 | 3 months | ER; DR Time of PC starting to rise; Time of PC rising to normal |
14 | Shi L [43] | 2019 | RCT | 32 | 32 | Not reported | ER; AR Time of PC rising to normal; Time of achieving hemostasis |
15 | Liang CJ [37] | 2017 | RCT | 28 | 26 | Not reported | ER; AR Time of PC rising to normal; Time of achieving hemostasis |
16 | Tan YF [39] | 2016 | RCT | 28 | 28 | 3 months | ER; DR Time of PC starting to rise; Time of PC rising to normal |
17 | Liu LK [40] | 2003 | RCT | 45 | 45 | Not reported | ER |
18 | Yang B [46] | 2013 | RCT | 55 | 55 | Not reported | ER; AR Time of PC rising to normal; Time of achieving hemostasis |
19 | Wang Y [45] | 2022 | RCT | 19 | 19 | Not reported | ER |
20 | Jin Y [36] | 2020 | RCT | 25 | 25 | Not reported | ER |
21 | Yang Y [32] | 2022 | RCT | 51 | 51 | Not reported | ER Time of PC starting to rise; Time of PC rising to normal; Time of achieving hemostasis |
22 | Hu XL [33] | 2018 | RCT | 50 | 50 | 3 months | ER; DR |
23 | Gong CX [31] | 2016 | Cohort study | 30 | 33 | 18 months | ER; DR |
24 | Liu YY [41] | 2008 | Cohort study | 27 | 32 | Not reported | ER |
25 | Huang HY [28] | 2022 | Cohort study | 41 | 41 | Not reported | ER; AR |